what a good year for onxx

The company with Nexavar. Approved for liver cancer. On the news of the success the stock rose from $12 to $57 over the year. That is a market cap of just over $3Billion.
Success against liver cancer would see SBP go ballistic.
Have a happy and prosperous new year.
http://moneycentral.msn.com/investor/charts/chartdl.aspx?Symbol=ONXX&D4=1&ViewType=0&&ShowChtBt=Refresh+Chart&DateRangeForm=1&ComparisonsForm=1&D5=0&CP=0&PT=5&CE=0&3=0&PeriodType=5&C9=0&DisplayForm=1